Companies / Lyell Immunopharma, Inc. / Activity
Activity — Lyell Immunopharma, Inc.
2 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | ARCH Venture Partners IX, LLC 10% owner | Buy | Common Stock | $12.50M | +488K +52.01% | 1,426,528 5.82% of shares | high |
| Mar 6, 2026 | ARCH Venture Fund XIII, L.P. 10% owner | Buy | Common Stock | $12.50M | +488K +52.01% | 1,426,528 5.82% of shares | high |